T cell immunity is central for the control of viral infections. To characterize T cell immunity,
but also for the development of vaccines, identification of exact viral T cell epitopes is …

T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine
candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins 1 …

Long-term immunological memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is crucial for the development of population-level immunity, which is the aim of …

Microbial organisms have key roles in numerous physiological processes in the human body
and have recently been shown to modify the response to immune checkpoint inhibitors 1 , …

The approach of peptide-based anticancer vaccination has proven the ability to induce
cancer-specific immune responses in multiple studies for various cancer entities. However, …

Background & Aims Non-alcoholic steatohepatitis (NASH) represents the fastest growing
underlying cause of hepatocellular carcinoma (HCC) and has been shown to impact immune …

Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer
therapy by releasing the power of the immune system. However, only little is known about the …

Several COVID-19 vaccines are approved to prevent severe disease outcome after SARS-CoV-2
infection. Whereas induction and functionality of antiviral antibody response are largely …

Immunological methods to detect SARS-CoV-2 seroconversion in humans are important to
track COVID-19 cases and the humoral response to SARS-CoV-2 infections and …

The DNAJB1-PRKACA fusion transcript is the oncogenic driver in fibrolamellar hepatocellular
carcinoma, a lethal disease lacking specific therapies. This study reports on the …